A groundbreaking study has revealed a surprising link between certain blood cancer mutations and Alzheimer’s disease. Researchers found that mutations commonly associated with blood cancers may contribute to the development of Alzheimer’s by producing overly inflammatory immune cells that affect the brain.
These immune cells can promote chronic inflammation, a process increasingly recognized as a key driver of neurodegenerative diseases. The discovery offers a new perspective on how Alzheimer’s may develop and opens the door to innovative diagnostic and treatment approaches.
Scientists believe the findings could eventually lead to blood-based screening tests for early detection and even inspire new therapies for Alzheimer’s using strategies already employed in cancer medicine.
Read more at ScienceDaily